Why are Newborns Screened for CF?|
Why is it important to screen for cystic fibrosis (CF) at birth?
It is important to diagnose CF early, so that CF health care providers can help parents learn ways to keep their child as healthy as possible and delay problems related to CF. Research shows that children who receive CF care early in life have better nutrition and are healthier than those who are diagnosed later. Good nutrition in CF is important for overall health and well-being.What does the CF newborn screening test check for?
The CF screening test checks for a chemical made by the pancreas, an organ that helps with digestion. This chemical is called immunoreactive trypsinogen, or IRT. It is normally found in small amounts in the body.
When the pancreas is stressed before a baby is born, more IRT is released into the baby’s blood. The IRT can be high if a baby is premature or had a stressful delivery, or for other reasons. The IRT tends to be high in people who have CF.
However, most states now do a second blood test on the first newborn screening blood sample to check for changes in the gene that causes cystic fibrosis.
Yes. Each state's CF newborn screening program begins with a test on blood from a baby. In some states, a second blood test is done when your baby is about two weeks old to find out if the IRT level is still high. This is called an IRT-only method of newborn screening.
A newborn-screening method called IRT-DNA, provides more information about how likely it is that a baby has CF. It is important to remember that even this DNA testing is still only a “screen” for CF. It is not a diagnosis.
Your baby’s newborn screening report will show whether genetic testing was done and what the results are.
All 50 states and the District of Columbia screen newborns for CF, but the method for screening may differ from state to state. Using the map below, click on the state where your baby was born to see which newborn screening method is used.
If your baby was born in an IRT-only state and had a high IRT level on the first blood test, he or she will need to have the IRT test repeated at your pediatrician’s office. In many IRT only states, all babies routinely have a repeat newborn screening test (blood test) when they are about two weeks old.
If the IRT remains high on the second test, you will be asked to bring your baby to a CF Foundation-accredited care center for a sweat test to find out whether or not your baby has CF.
For IRT-DNA states, how was my baby screened?
If your baby was born in an IRT-DNA state and had a high IRT level on the first blood test, he or she will automatically have a blood test to check for changes, or mutations, in the CF gene.
Based on your baby’s newborn screening results, you may be asked to bring your baby to a CF Foundation-accredited care center for sweat testing.
The number of CF gene mutations found in your baby's newborn screen helps to find out how likely it is your baby has CF. Your baby’s newborn screening report may list how many and what kind of mutations were found on the newborn screening result.
No. CF newborn screening finds babies who have cystic fibrosis. However, some states include DNA testing for some CF gene mutations. The DNA test may find some but not all babies who are CF carriers. If you have questions, please contact a CF Foundation-accredited care center or talk with your doctor.